| PACKAGING TYPE: | 10ml C-box |
| COMPOSITION: | Teicoplanin (400mg) |
| FORMULATION: | Injection |
| Description: | TARGOSAFE 400 Injection contains Teicoplanin 400 mg, a glycopeptide antibiotic used for the treatment of serious gram-positive bacterial infections, including resistant strains such as MRSA (Methicillin-resistant Staphylococcus aureus). It works by inhibiting bacterial cell wall synthesis, leading to bacterial death. This higher-strength formulation is commonly used in severe infections and as part of loading dose regimens in hospital and ICU settings. It is effective in conditions such as septicemia, endocarditis, respiratory infections, skin and soft tissue infections, and bone infections. |
| Side Effects: | Injection site reactions Fever or chills Rash or allergic reactions Rare kidney toxicity Rare hearing disturbances |
| How to Use: | To be administered by healthcare professionals only Given via IV or IM route as prescribed Often used as a loading dose followed by maintenance therapy Dosage based on infection severity and patient condition |
| Precaution: | For hospital use only Monitor renal function during therapy Use cautiously in renal impairment Watch for hypersensitivity reactions Not for self-administration |
| Product Benefits: | Strong activity against gram-positive bacteria Effective against MRSA and resistant organisms Higher dose suitable for severe infections Long half-life allows convenient dosing Lower nephrotoxicity compared to some alternatives Ideal for ICU and crit |
Frequently Asked Questions
It is used for severe gram-positive infections including MRSA.
400 mg is a higher strength used in severe infections or loading dose therapy.
Yes, under medical supervision with proper monitoring.










